SCHEMBL21667374

SCHEMBL21667374

CC(C)n1c(=O)cc(NCc2cccc(O)c2)[nH]c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.52
▸ CYP2B6 P20813 1/20 0.52
▸ CDK1 P06493 3/20 0.42
▸ CCNB2 O95067 2/20 0.42
▸ CCNB1 P14635 2/20 0.42
▸ CCNB3 Q8WWL7 2/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ LMNA P02545 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667306 0.86 CYP3A4 (0.50) CYP3A4CYP2B6KMT2AMEN1SMN1; SMN2
SCHEMBL21667347 0.86 CYP3A4 (0.50) CYP3A4CYP2B6KMT2AMEN1SMN1; SMN2
SCHEMBL20716038 0.86 CYP3A4 (0.61) CYP3A4CYP2B6CDK1KMT2AMEN1
SCHEMBL21667176 0.85 CYP3A4 (0.49) CYP3A4CYP2B6KMT2AMEN1SMN1; SMN2
SCHEMBL21667309 0.85 CYP3A4 (0.49) CYP3A4CYP2B6KMT2AMEN1SMN1; SMN2
SCHEMBL21667252 0.83 PDE9A (0.50) CYP3A4CYP2B6CDK1KMT2AMEN1
SCHEMBL21667270 0.80 KMT2A (0.64) CYP3A4CYP2B6KMT2AMEN1SMN1; SMN2
SCHEMBL16322273 0.79 CYP3A4 (0.74) CYP3A4CYP2B6SMN1; SMN2LMNANFKB1
SCHEMBL21667350 0.79 CYP3A4 (0.53) CYP3A4CYP2B6CDK1CCNB2CCNB1
SCHEMBL16322270 0.79 CYP3A4 (0.74) CYP3A4CYP2B6SMN1; SMN2LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback